Skip to main content
Clinical Trials/ChiCTR2000039764
ChiCTR2000039764Active, not recruitingPhase 4

利多卡因术中泵注对甲状腺切除术患者术后睡眠的影响: 一项随机、对照、双盲的前瞻性研究

自筹1 site in 1 country60 target enrollmentStarted: November 2, 2020Last updated:

Trial Snapshot

Phase
Phase 4
Status
Active, not recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
匹兹堡睡眠质量指数

Study Overview

Brief Summary

评估术中静脉泵注利多卡因对甲状腺肿瘤切除手术患者术后睡眠影响。

Study Design

Study Type
干预性研究
Primary Purpose
随机平行对照
Masking
双盲

Eligibility Criteria

Ages
18 to 45 (—)
Sex
Female

Inclusion Criteria

  • (1)18 岁≤年龄≤45 岁;
  • (3)18.5kg/m2 ≦ BMI ≦ 23.9kg/m2;
  • (4)择期行甲状腺肿瘤切除术;
  • (5)ASA I 或 II 级;
  • (6)签署知情同意书.

Exclusion Criteria

  • (1)局部麻醉药过敏史;
  • (2)甲状腺功能亢进或甲状腺功能减退;
  • (3)既往有焦虑抑郁等精神疾病或是睡眠障碍;
  • (4)围手术期使用镇静及镇痛药物;
  • (5)充血性心力衰竭;
  • (7)有肾功能衰竭、肝功能衰竭;

Arms & Interventions

利多卡因组

利多卡因诱导、术中泵注

生理盐水组

相同容量生理盐水输注

Outcomes

Primary Outcomes

匹兹堡睡眠质量指数

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
自筹

Study Sites (1)

Loading locations...

Similar Trials